Incidence, risk factors, and outcomes of the transition of HIPEC-induced acute kidney injury to acute kidney disease: a retrospective study

References

• Thakar CV. Perioperative acute kidney injury. Adv Chronic Kidney Dis. 2013;20(1):1–13. doi: 10.1053/j.ackd.2012.10.003.
   PubMed Web of Science ®Google Scholar
• Thakar CV, Christianson A, Freyberg R, et al. Incidence and outcomes of acute kidney injury in intensive care units: a veterans administration study. Crit Care Med. 2009;37(9):2552–2558. doi: 10.1097/CCM.0b013e3181a5906f.
   PubMed Web of Science ®Google Scholar
• Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442–448. doi: 10.1038/ki.2011.379.
   PubMed Web of Science ®Google Scholar
• Coca SG, Yusuf B, Shlipak MG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53(6):961–973. doi: 10.1053/j.ajkd.2008.11.034.
   PubMed Web of Science ®Google Scholar
• Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365–3370. doi: 10.1681/ASN.2004090740.
   PubMed Web of Science ®Google Scholar
• Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13(4):241–257. doi: 10.1038/nrneph.2017.2.
   PubMed Web of Science ®Google Scholar
• Matsuura R, Iwagami M, Moriya H, et al. The clinical course of acute kidney disease after cardiac surgery: a retrospective observational study. Sci Rep. 2020;10(1):6490. doi: 10.1038/s41598-020-62981-1.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29–42. doi: 10.1097/00000658-199501000-00004.
   PubMed Web of Science ®Google Scholar
• Bhatt A, Sheshadri D, Chandan G, et al. Outcomes of cytoreductive surgery and HIPEC for pseudomyxoma peritonei of appendiceal origin from two Indian centers: a preliminary five-year experience. J BUON. 2017;22(1):251–257.
   PubMed Web of Science ®Google Scholar
• Bonnot P-E, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37(23):2028–2040. doi: 10.1200/JCO.18.01688.
   PubMed Web of Science ®Google Scholar
• Yang X-J, Huang C-Q, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575–1581. doi: 10.1245/s10434-011-1631-5.
   PubMed Web of Science ®Google Scholar
• Esquivel J, Lowy AM, Markman M, et al. The American Society of Peritoneal Surface Malignancies (ASPSM) multiinstitution evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 patients with colorectal cancer with peritoneal carcinomatosis. Ann Surg Oncol. 2014;21(13):4195–4201. doi: 10.1245/s10434-014-3798-z.
   PubMed Web of Science ®Google Scholar
• van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378(3):230–240. doi: 10.1056/NEJMoa1708618.
   PubMed Web of Science ®Google Scholar
• Baratti D, Kusamura S, Cabras AD, et al. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Cancer. 2013;49(15):3140–3148. doi: 10.1016/j.ejca.2013.05.027.
   PubMed Web of Science ®Google Scholar
• Schwarz L, Votanopoulos K, Morris D, et al. Is the combination of distal pancreatectomy and cytoreductive surgery with HIPEC reasonable? Results of an international multicenter study. Ann Surg. 2016;263(2):369–375. doi: 10.1097/SLA.0000000000001225.
   PubMed Web of Science ®Google Scholar
• Mehta S, Schwarz L, Spiliotis J, et al. Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study. Eur J Surg Oncol. 2018;44(11):1786–1792. doi: 10.1016/j.ejso.2018.05.021.
   PubMed Web of Science ®Google Scholar
• Lee L, Alie-Cusson F, Dubé P, et al. Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis. J Surg Oncol. 2017;116(2):236–243. doi: 10.1002/jso.24632.
   PubMed Web of Science ®Google Scholar
• Angeles MA, Quenet F, Vieille P, et al. Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis. Int J Gynecol Cancer. 2019;29(2):382–391. doi: 10.1136/ijgc-2018-000099.
   PubMed Web of Science ®Google Scholar
• Haslinger M, Francescutti V, Attwood K, et al. A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion. Cancer Med. 2013;2(3):334–342. doi: 10.1002/cam4.80.
   PubMed Web of Science ®Google Scholar
• Bouhadjari N, Gabato W, Calabrese D, et al. Hyperthermic intraperitoneal chemotherapy with cisplatin: amifostine prevents acute severe renal impairment. Eur J Surg Oncol. 2016;42(2):219–223. doi: 10.1016/j.ejso.2015.07.016.
   PubMed Web of Science ®Google Scholar
• Cata JP, Zavala AM, Van Meter A, et al. Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective study. Int J Hyperthermia. 2018;34(5):538–544. doi: 10.1080/02656736.2017.1368096.
   PubMed Web of Science ®Google Scholar
• Hakeam HA, Breakiet M, Azzam A, et al. The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery. Ren Fail. 2014;36(10):1486–1491. doi: 10.3109/0886022X.2014.949758.
   PubMed Web of Science ®Google Scholar
• Sin EI-L, Chia CS, Tan GHC, et al. Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. Int J Hyperthermia. 2017;33(6):690–695. doi: 10.1080/02656736.2017.1293304.
   PubMed Web of Science ®Google Scholar
• Ye J, Ren Y, Wei Z, et al. Nephrotoxicity and long-term survival investigations for patients with peritoneal carcinomatosis using hyperthermic intraperitoneal chemotherapy with cisplatin: a retrospective cohort study. Surg Oncol. 2018;27(3):456–461. doi: 10.1016/j.suronc.2018.05.025.
   PubMed Web of Science ®Google Scholar
• Fliser D, Laville M, Covic A, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27(12):4263–4272. doi: 10.1093/ndt/gfs375.
   PubMed Web of Science ®Google Scholar
• Hsu C-K, Wu I-W, Chen Y-T, et al. Acute kidney disease stage predicts outcome of patients on extracorporeal membrane oxygenation support. PLOS One. 2020;15(4):e0231505. doi: 10.1371/journal.pone.0231505.
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737–3743. doi: 10.1200/JCO.2003.04.187.
   PubMed Web of Science ®Google Scholar
• Albanese AM, Albanese EF, Miño JH, et al. Peritoneal surface area: measurements of 40 structures covered by peritoneum: correlation between total peritoneal surface area and the surface calculated by formulas. Surg Radiol Anat. 2009;31(5):369–377. doi: 10.1007/s00276-008-0456-9.
   PubMed Web of Science ®Google Scholar
• Dalfino L, Tullo L, Donadio I, et al. Intra-abdominal hypertension and acute renal failure in critically ill patients. Intensive Care Med. 2008;34(4):707–713. doi: 10.1007/s00134-007-0969-4.
   PubMed Web of Science ®Google Scholar
• Gonçalves GM, Zamboni DS, Câmara NO. The role of innate immunity in septic acute kidney injuries. Shock. 2010;34(7):22–26. doi: 10.1097/SHK.0b013e3181e7e69e.
   PubMedGoogle Scholar
• Shankar A, Sun L, Klein BEK, et al. Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int. 2011;80(11):1231–1238. doi: 10.1038/ki.2011.283.
   PubMed Web of Science ®Google Scholar
• POISE Study Group, Devereaux PJ, Yang H, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371(9627):1839–1847.
   PubMed Web of Science ®Google Scholar
• Walsh M, Devereaux PJ, Garg AX, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119(3):507–515. doi: 10.1097/ALN.0b013e3182a10e26.
   PubMed Web of Science ®Google Scholar
• McSweeney KR, Gadanec LK, Qaradakhi T, et al. Mechanisms of cisplatin-induced acute kidney injury: pathological mechanisms, pharmacological interventions, and genetic mitigations. Cancers. 2021;13(7):1572. doi: 10.3390/cancers13071572.
   PubMed Web of Science ®Google Scholar
• Manohar S, Leung N. Cisplatin nephrotoxicity: a review of the literature. J Nephrol. 2018;31(1):15–25. doi: 10.1007/s40620-017-0392-z.
   PubMed Web of Science ®Google Scholar
• Kellum JA, Sileanu FE, Bihorac A, et al. Recovery after acute kidney injury. Am J Respir Crit Care Med. 2017;195(6):784–791. doi: 10.1164/rccm.201604-0799OC.
   PubMed Web of Science ®Google Scholar
• Peerapornratana S, Priyanka P, Wang S, et al. Sepsis-associated acute kidney disease. Kidney Int Rep. 2020;5(6):839–850. doi: 10.1016/j.ekir.2020.03.005.
   PubMed Web of Science ®Google Scholar
• Mehta S, Chauhan K, Patel A, et al. The prognostic importance of duration of AKI: a systematic review and meta-analysis. BMC Nephrol. 2018;19(1):91. doi: 10.1186/s12882-018-0876-7.
   PubMedGoogle Scholar
• Grams ME, Astor BC, Bash LD, et al. Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury. J Am Soc Nephrol. 2010;21(10):1757–1764. doi: 10.1681/ASN.2010010128.
   PubMed Web of Science ®Google Scholar
• Grams ME, Sang Y, Ballew SH, et al. A meta-analysis of the association of estimated GFR, albuminuria, age, race, and sex with acute kidney injury. Am J Kidney Dis. 2015;66(4):591–601. doi: 10.1053/j.ajkd.2015.02.337.
   PubMed Web of Science ®Google Scholar
• James MT, Grams ME, Woodward M, et al. A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury. Am J Kidney Dis. 2015;66(4):602–612. doi: 10.1053/j.ajkd.2015.02.338.
   PubMed Web of Science ®Google Scholar
• Ben-Dov IZ, Kark JD. Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic Cohort Study. Nephrol Dial Transplant. 2011;26(8):2558–2566. doi: 10.1093/ndt/gfq740.
   PubMed Web of Science ®Google Scholar
• Jalal DI, Chonchol M, Chen W, et al. Uric acid as a target of therapy in CKD. Am J Kidney Dis. 2013;61(1):134–146. doi: 10.1053/j.ajkd.2012.07.021.
   PubMed Web of Science ®Google Scholar
• Saugel B, Sessler DI. Perioperative blood pressure management. Anesthesiology. 2021;134(2):250–261. doi: 10.1097/ALN.0000000000003610.
   PubMed Web of Science ®Google Scholar
• Futier E, Lefrant J-Y, Guinot P-G, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA. 2017;318(14):1346–1357. doi: 10.1001/jama.2017.14172.
   PubMed Web of Science ®Google Scholar
• Dünser MW, Takala J, Ulmer H, et al. Arterial blood pressure during early sepsis and outcome. Intensive Care Med. 2009;35(7):1225–1233. doi: 10.1007/s00134-009-1427-2.
   PubMed Web of Science ®Google Scholar
• Sun LY, Wijeysundera DN, Tait GA, et al. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015;123(3):515–523. doi: 10.1097/ALN.0000000000000765.
   PubMed Web of Science ®Google Scholar
• Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22(16):3284–3292. doi: 10.1200/JCO.2004.10.012.
   PubMed Web of Science ®Google Scholar
• Desantis M, Bernard J-L, Casanova V, et al. Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC). Langenbecks Arch Surg. 2015;400(1):37–48. doi: 10.1007/s00423-014-1253-z.
   PubMed Web of Science ®Google Scholar
• Malfroy S, Wallet F, Maucort-Boulch D, et al. Complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: risk factors for ICU admission and morbidity prognostic score. Surg Oncol. 2016;25(1):6–15. doi: 10.1016/j.suronc.2015.11.003.
   PubMed Web of Science ®Google Scholar
• Naffouje SA, Tulla KA, Chorley R, et al. Acute kidney injury increases the rate of major morbidities in cytoreductive surgery and HIPEC. Ann Med Surg. 2018;35:163–168. doi: 10.1016/j.amsu.2018.09.036.
   PubMed Web of Science ®Google Scholar